Stem-cell funding passes House, faces veto threat

[Eddie Franklin]

An interesting otc stock for your consideration.


Sym bol: VTSS
On: PinkSheets
5-Days Target: $2.00
Long Term Target: $8.50

Take a look at the annoucement and reveiw the technology, but grab some VTSS
before they drop the release to push this stock to the dollar marker.


IS MOMENTUM BUILDING FOR THIS STOCK? IS IT READY TO MOVE?
GO LOOK AT THE CHART RIGHT NOW!